SCHEMBL4158869

SCHEMBL4158869

Cn1cc(-c2cccc(NC(=O)c3ccccc3C(C)(C)C)c2F)nc(Nc2ccc(C(=O)N3CCC(=O)CC3)cc2)c1=O

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1066887 0.90 BTK (0.71) BTK
SCHEMBL27716882 0.86 BTK (0.54) BTK
SCHEMBL28414908 0.84 BTK (0.81) BTK
SCHEMBL5243047 0.84 BTK (0.67) BTK
SCHEMBL1067788 0.83 BTK (0.72) BTK
SCHEMBL1070823 0.82 BTK (0.71) BTK
SCHEMBL1066196 0.82 BTK (0.70) BTK
SCHEMBL16716418 0.82 BTK (0.70) BTK
SCHEMBL1069162 0.82 BTK (0.85) BTK
SCHEMBL5242806 0.82 BTK (0.52) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068849-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI Pharmaceuticals, Inc. (US) 2009-06-17 EP disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed
EP-1863766-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI Pharmaceuticals, Inc. (US) 2007-12-12 EP disclosed
WO-2006099075-A2 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2006-09-21 WO disclosed